How AI is changing the pharmaceuticals landscape
Nintedanib, a widely used drug for pulmonary fibrosis, received official approval in 2014 after its development began in…
DeepMind CEO Demis Hassabis: ‘AI could cut drug discovery from years to…’; how it is changing medicine worldwide |
Artificial intelligence (AI) is rapidly transforming industries, and the pharmaceutical sector is poised to be one of its…